The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis
Open accessAbstract
OBJECTIVES: Existing findings regarding the relationship between comorbidities and the severity of coronavirus disease 2019 (COVID-19) are inconsistent and insufficient. The aim of this study was to evaluate the association between different comorbidities and the severity of COVID-19. METHODS: The PubMed, Embase, and Cochrane Library databases were searched to identify studies reporting the rates of comorbidities in COVID-19 patients with severe/fatal outcomes. Subgroup analyses were conducted according to disease severity and the country of residence. Odds ratios (OR) with 95% confidence intervals (CI) were pooled using random-effects models. RESULTS: A total of 34 eligible studies were identified. In patients with severe/fatal COVID-19, the most prevalent chronic comorbidities were obesity (42%, 95% CI 34-49%) and hypertension (40%, 95% CI 35-45%), followed by diabetes (17%, 95% CI 15-20%), cardiovascular disease (13%, 95% CI 11-15%), respiratory disease (8%, 95% CI 6-10%), cerebrovascular disease (6%, 95% CI 4-8%), malignancy (4%, 95% CI 3-6%), kidney disease (3%, 95% CI 2-4%), and liver disease (2%, 95% CI 1-3%). In order of the prediction, the pooled ORs of the comorbidities in patients with severe or fatal COVID-19 when compared to patients with non-severe/fatal COVID-19 were as follows: chronic respiratory disease, OR 3.56 (95% CI 2.87-4.41); hypertension, OR 3.17 (95% CI 2.46-4.08); cardiovascular disease, OR 3.13 (95% CI 2.65-3.70); kidney disease, OR 3.02 (95% CI 2.23-4.08); cerebrovascular disease, OR 2.74 (95% CI 1.59-4.74); malignancy, OR 2.73 (95% CI 1.73-4.21); diabetes, OR 2.63 (95% CI 2.08-3.33); and obesity, OR 1.72 (95% CI 1.04-2.85). No correlation was observed between liver disease and COVID-19 aggravation (OR 1.54, 95% CI 0.95-2.49). CONCLUSIONS: Chronic comorbidities, including obesity, hypertension, diabetes, cardiovascular disease, cerebrovascular disease, respiratory disease, kidney disease, and malignancy are clinical risk factors for a severe or fatal outcome associated with COVID-19, with obesity being the most prevalent and respiratory disease being the most strongly predictive. Knowledge of these risk factors could help clinicians better identify and manage the high-risk populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19)
Zhu, Y., Gao, Z.-H., Liu, Y.-L., Xu, D.-Y., Guan, T.-M., Li, Z.-P., Kuang, J.-Y., Li, X.-M., Yang, Y.-Y., & Feng, S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.033 · Cited by 139
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Self-citationBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469 · cited 3×
“, 2020b), seven reported retrospective case series (Goyal et al., 2020; Grasselli et al., 2020; Wan et al., 2020; Wang et al., 2020a; Wang et al., 2020b; Young et al., 2020; Zheng et al., 2020c), and four reported surveillance studies (studies extracting data from a database of cases, systematically gathering epidemio…”
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Self-citationTransmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Janke, C., Guggemos, W., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001468 · Cited by 4,144
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903 · cited 6×
“…National Incident Room Surveillance Team, 2020, CDC COVID-19 Response Team, 2020; Barrasa et al., 2020; Cai et al., 2020; Chen et al., 2020b; Chen et al., 2020; Deng et al., 2020; Feng et al., 2020; Gao et al., 2020; Goyal et al., 2020; Grasselli et al., 2020; Guan et al., 2020a,b; Huang et…”
BackgroundInfluentialComorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis
Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00547-2020 · Cited by 3,680
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Emanuel, E. J., Persad, G., Upshur, R., Thome, B., Parker, M., Glickman, A., Zhang, C., Boyle, C., Smith, M., & Phillips, J. P. (2020) · New England Journal of Medicine · doi:10.1056/nejmsb2005114 · Cited by 3,137
COVID-19 and the cardiovascular system
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684
Clinical Characteristics of Covid-19 in New York City
Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M. J., Campion, T. R., Nahid, M., Ringel, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010419 · Cited by 2,234
Stewart, L. A., Clarke, M., Rovers, M., Riley, R. D., Simmonds, M., Stewart, G., & Tierney, J. F. (2015) · JAMA · doi:10.1001/jama.2015.3656 · Cited by 2,134
Simonnet, A., Chetboun, M., Poissy, J., Raverdy, V., Noulette, J., Duhamel, A., Labreuche, J., Mathieu, D., Pattou, F., Jourdain, M., et al. (2020) · Obesity · doi:10.1002/oby.22831 · Cited by 2,079
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Young, B. E., Ong, S. W. X., Kalimuddin, S., Low, J. G., Tan, S. Y., Loh, J., Ng, O.-T., Marimuthu, K., Ang, L. W., Mak, T. M., et al. (2020) · JAMA · doi:10.1001/jama.2020.3204 · Cited by 2,059
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L., Bi, Z., & Zhao, Y. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01626-9 · Cited by 2,057
Zheng, S., Fan, J., Yu, F., Feng, B., Lou, B., Zou, Q., Xie, G., Lin, S., Wang, R., Yang, X., et al. (2020) · BMJ · doi:10.1136/bmj.m1443 · Cited by 1,440
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
Booth, C. M. (2003) · JAMA · doi:10.1001/jama.289.21.joc30885 · Cited by 1,406
Diabetes is a risk factor for the progression and prognosis of COVID‐19
Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., Qin, R., Wang, H., Shen, Y., Du, K., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3319 · Cited by 1,404 · cited 10×
“Given the virtually unstoppable global trend of SARS-CoV-2, together with the high prevalence of comorbidities worldwide, the combination of these two conditions will pose greater clinical, societal, and economic burdens to humanity (Emanuel et al., 2020).”
BackgroundInfluentialCDC COVID-19 Response Team, CDC COVID-19 Response Team, Chow, N., Fleming-Dutra, K., Gierke, R., Hall, A., Hughes, M., Pilishvili, T., Ritchey, M., Roguski, K., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6913e2 · Cited by 1,404
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
Wang, B., Li, R., Lu, Z., & Huang, Y. (2020) · Aging · doi:10.18632/aging.103000 · Cited by 1,304
The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia
Li, K., Wu, J., Wu, F., Guo, D., Chen, L., Fang, Z., & Li, C. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000672 · Cited by 1,268
Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam
Phan, L. T., Nguyen, T. V., Luong, Q. C., Nguyen, T. V., Nguyen, H. T., Le, H. Q., Nguyen, T. T., Cao, T. M., & Pham, Q. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001272 · Cited by 1,137
Liu, W., Tao, Z.-W., Wang, L., Yuan, M.-L., Liu, K., Zhou, L., Wei, S., Deng, Y., Liu, J., Liu, H.-G., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000775 · Cited by 1,104
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Yang, J.-K., Lin, S.-S., Ji, X.-J., & Guo, L.-M. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0109-4 · Cited by 1,084
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19
Gao, Y., Li, T., Han, M., Li, X., Wu, D., Xu, Y., Zhu, Y., Liu, Y., Wang, X., & Wang, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25770 · Cited by 1,047
Chen, X., Zhao, B., Qu, Y., Chen, Y., Xiong, J., Feng, Y., Men, D., Huang, Q., Liu, Y., Yang, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa449 · Cited by 1,020
Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing
Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., Lang, C., Huang, D., Sun, Q., Xiong, Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25783 · Cited by 982
Self-citationDysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Quasispecies Theory and the Behavior of RNA Viruses
Lauring, A. S., & Andino, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001005 · Cited by 846
COVID-19 with Different Severities: A Multicenter Study of Clinical Features
Feng, Y., Ling, Y., Bai, T., Xie, Y., Huang, J., Li, J., Xiong, W., Yang, D., Chen, R., Lu, F., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0445oc · Cited by 838
Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China
Deng, S.-Q., & Peng, H.-J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020575 · Cited by 718
Badawi, A., & Ryoo, S. G. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.06.015 · Cited by 703
Cardiac and arrhythmic complications in patients with COVID‐19
Kochi, A. N., Tagliari, A. P., Forleo, G. B., Fassini, G. M., & Tondo, C. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14479 · Cited by 666
Deng, Y., Liu, W., Liu, K., Fang, Y.-Y., Shang, J., Zhou, L., Wang, K., Leng, F., Wei, S., Chen, L., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000824 · Cited by 657
Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis
Mertz, D., Kim, T. H., Johnstone, J., Lam, P.-P., Science, M., Kuster, S. P., Fadel, S. A., Tran, D., Fernandez, E., Bhatnagar, N., et al. (2013) · BMJ · doi:10.1136/bmj.f5061 · Cited by 634
Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis
Borges do Nascimento, I. J., Cacic, N., Abdulazeem, H. M., von Groote, T. C., Jayarajah, U., Weerasekara, I., Esfahani, M. A., Civile, V. T., Marusic, A., Jeroncic, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040941 · Cited by 629
ACE2: from vasopeptidase to SARS virus receptor
Turner, A. J., Hiscox, J. A., & Hooper, N. M. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.04.001 · Cited by 517
Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition
Hameed, I., Masoodi, S. R., Mir, S. A., Nabi, M., Ghazanfar, K., & Ganai, B. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i4.598 · Cited by 506
COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z., Su, Y., Ma, Z., Zhang, Y., Li, Z., et al. (2020) · Allergy · doi:10.1111/all.14309 · Cited by 502
Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia
Wang, F., Wang, H., Fan, J., Zhang, Y., Wang, H., & Zhao, Q. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.055 · Cited by 459
Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis
Lippi, G., Wong, J., & Henry, B. M. (2020) · Polish Archives of Internal Medicine · doi:10.20452/pamw.15272 · Cited by 421
Chan, J. W. M. (2003) · Thorax · doi:10.1136/thorax.58.8.686 · Cited by 394
McLaughlin, T., Liu, L.-F., Lamendola, C., Shen, L., Morton, J., Rivas, H., Winer, D., Tolentino, L., Choi, O., Zhang, H., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304636 · Cited by 364
Self-citationRyan, P. M., & Caplice, N. M. (2020) · Obesity · doi:10.1002/oby.22843 · Cited by 321
Impact of Body Mass Index on Outcomes Following Critical Care
Tremblay, A., & Bandi, V. (2003) · Chest · doi:10.1378/chest.123.4.1202 · Cited by 318
Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse
Roca-Ho, H., Riera, M., Palau, V., Pascual, J., & Soler, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030563 · Cited by 301
Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID‐19
Zhou, Y., Han, T., Chen, J., Hou, C., Hua, L., He, S., Guo, Y., Zhang, S., Wang, Y., Yuan, J., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12805 · Cited by 294
Self-citationCross-Sectional and Prospective Study of Lung Function in Adults With Type 2 Diabetes
Yeh, H.-C., Punjabi, N. M., Wang, N.-Y., Pankow, J. S., Duncan, B. B., Cox, C. E., Selvin, E., & Brancati, F. L. (2008) · Diabetes Care · doi:10.2337/dc07-1464 · Cited by 257
Fezeu, L., Julia, C., Henegar, A., Bitu, J., Hu, F. B., Grobbee, D. E., Kengne, A.-P., Hercberg, S., & Czernichow, S. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00864.x · Cited by 236
SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria
Barrasa, H., Rello, J., Tejada, S., Martín, A., Balziskueta, G., Vinuesa, C., Fernández-Miret, B., Villagra, A., Vallejo, A., San Sebastián, A., et al. (2020) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2020.04.001 · Cited by 208
Analysis of 92 deceased patients with COVID‐19
Yang, F., Shi, S., Zhu, J., Shi, J., Dai, K., & Chen, X. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25891 · Cited by 199
Retrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients
Yao, Q., Wang, P., Wang, X., Qie, G., Meng, M., Tong, X., Bai, X., Ding, M., Liu, W., Keke, L., et al. (2020) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15312 · Cited by 178
Zheng, Y., Xu, H., Yang, M., Zeng, Y., Chen, H., Liu, R., Li, Q., Zhang, N., & Wang, D. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104366 · Cited by 176
Influence of Overweight on ICU Mortality
Goulenok, C., Monchi, M., Chiche, J.-D., Mira, J.-P., Dhainaut, J.-F., & Cariou, A. (2004) · Chest · doi:10.1378/chest.125.4.1441 · Cited by 175
Obesity is associated with increased morbidity but not mortality in critically ill patients
Sakr, Y., Madl, C., Filipescu, D., Moreno, R., Groeneveld, J., Artigas, A., Reinhart, K., & Vincent, J.-L. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1243-0 · Cited by 172
Piva, S., Filippini, M., Turla, F., Cattaneo, S., Margola, A., De Fulviis, S., Nardiello, I., Beretta, A., Ferrari, L., Trotta, R., et al. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.04.004 · Cited by 171
Zhou, J., & Tan, J. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154216 · Cited by 161
Relationship of body mass index to subsequent mortality among seriously ill hospitalized patients
Galanos, A. N., Pieper, C. F., Kussin, P. S., Winchell, M. T., Fulkerson, W. J., Harrell, F. E., Teno, J. M., Layde, P. M., Connors, A. F., Phillips, R. S., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199712000-00010 · Cited by 150
Alqahtani, F. Y., Aleanizy, F. S., Mohamed, R. A. E. H., Alanazi, M., Mohamed, N., Al-Rasheed, M. M., Abanmy, N. O., & Alhawassi, T. M. (2018) · Epidemiology and Infection · doi:10.1017/s0950268818002923 · Cited by 147
Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS
Liang, K. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104306 · Cited by 145
Two Things about COVID-19 Might Need AttentionPreprint
Jia, X., Yin, C., Lu, S., Chen, Y., Liu, Q., Bai, J., & Lu, Y. (2020) · Preprints.org · doi:10.20944/preprints202002.0315.v1 · Cited by 142
Martı́nez, A., Soldevila, N., Romero-Tamarit, A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210353 · Cited by 141
Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea
COVID-19 National Emergency Response Center, E. C. (2020) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2020.11.2.05 · Cited by 136
Peake, S., Moran, J. L., Ghelani, D. R., Lloyd, A. J., & Walker, M. J. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000248726.75699.b1 · Cited by 124
Matsuyama, R., Nishiura, H., Kutsuna, S., Hayakawa, K., & Ohmagari, N. (2016) · BMC Public Health · doi:10.1186/s12889-016-3881-4 · Cited by 124
Garbati, M. A., Fagbo, S. F., Fang, V. J., Skakni, L. I., Joseph, M. V., Wani, T. A., Cowling, B. J., Peiris, M. J. S., & Hakawi, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165978 · Cited by 111
The burden of influenza complications in different high-risk groups: a targeted literature review
Mauskopf, J., Klesse, M., Lee, S., & Herrera‐Taracena, G. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.752376 · Cited by 101
Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome
Yang, Y.-M., Hsu, C.-Y., Lai, C.-C., Yen, M., Wikramaratna, P. S., Chen, H.-H., & Wang, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-10402-1 · Cited by 71
Association of Obesity with Increased Mortality in the Critically Ill Patient
Aldawood, A. S., Arabi, Y. M., & Dabbagh, O. C. (2006) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0603400501 · Cited by 65
Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi Arabia
Alanazi, K. H., Abedi, G. R., Midgley, C. M., Alkhamis, A. M., Alsaqer, T. A., Almoaddi, A., Algwizani, A. R., Ghazal, S., Assiri, A. M., Jokhdar, H., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2601.190952 · Cited by 47
Ashburn, D. D., DeAntonio, A., & Reed, M. J. (2010) · Critical Care Clinics · doi:10.1016/j.ccc.2010.06.008 · Cited by 43
RNA virus evolution, population dynamics, and nutritional status
Domingo, E. (1997) · Biological Trace Element Research · doi:10.1007/bf02778981 · Cited by 28
Placzek, H., & Madoff, L. C. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.302197 · Cited by 25
Cardiac and arrhythmic complications in Covid-19 patients.Preprint
Kochi, A. N. (2020) · doi:10.22541/au.158594433.36475644 · Cited by 19
Cited by
Obesity in patients with COVID-19: a systematic review and meta-analysis
Huang, Y., Lu, Y., Huang, Y.-M., Wang, M., Ling, W., Sui, Y., & Zhao, H.-L. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154378 · Cited by 454
Racial Disparities in Incidence and Outcomes Among Patients With COVID-19
Muñoz-Price, L. S., Nattinger, A. B., Rivera, F., Hanson, R., Gmehlin, C. G., Perez, A., Singh, S., Buchan, B. W., Ledeboer, N. A., & Pezzin, L. E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.21892 · Cited by 358
Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity
Mercola, J., Grant, W. B., & Wagner, C. L. (2020) · Nutrients · doi:10.3390/nu12113361 · Cited by 272
Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis
Li, X., Zhong, X., Wang, Y., Zeng, X., Luo, T., & Liu, Q. (2021) · PLOS ONE · doi:10.1371/journal.pone.0250602 · Cited by 236
Self-citationDysfunctional purinergic signaling correlates with disease severity in COVID-19 patients
Pietrobon, A. J., Andrejew, R., Custódio, R. W. A., Oliveira, L. D. M., Scholl, J. N., Teixeira, F. M. E., de Brito, C. A., Glaser, T., Kazmierski, J., Goffinet, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1012027 · Cited by 23
Metadata
- Authors
- Zhou, Y., Yang, Q., Chi, J., Dong, B., Lv, W., Shen, L., & Wang, Y.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 99
- Pages
- 47-56
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W3044595037
- Cited by
- 407
- References
- 92
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.